| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/01/2006 | US20060117404 Soybean cultivar 1000126 |
| 06/01/2006 | US20060117403 Soybean cultivar 901023 |
| 06/01/2006 | US20060117402 Controlling gene expression; genetic engineered dna; transforming plant |
| 06/01/2006 | US20060117400 Introducing into plant plastids first and second DNA molecules containing a regions homologous to regions of the plastome for directing plastome integration and sequences of interest; selecting transformants having an integration sequence stably integrated in the plastome |
| 06/01/2006 | US20060117395 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 06/01/2006 | US20060117394 Chimeric cells coding heterologous immunoglobulin for treatment, prevention and diagnosis of infections and cell proliferative disorders |
| 06/01/2006 | US20060116506 Tenebrio antifreeze proteins |
| 06/01/2006 | US20060116340 Herpesvirus ribozymes and vectors |
| 06/01/2006 | US20060116338 Therapeutic and diagnostic tools for proliferative and developmental disorders and as vehicles for identifying region q26.2 on a mammalian chromosome 3; gene therapy; detecting Cornelia de Lange syndrome; diagnosing neoplasia; inducing a cell to change its pattern of differentiation |
| 06/01/2006 | US20060115901 Method and media for single cell serum-free culture of CHO cells |
| 06/01/2006 | US20060115900 Method of treating biological tissue by microwave-irradiation |
| 06/01/2006 | US20060115899 Methods of generating antigen-specific CD4+CD25+ regulatory T cells, compositions and methods of use |
| 06/01/2006 | US20060115898 Using nutrient broth comprising insulin-like growth factor-2 (IGF-2), and at least fibroblast growth factor (FGF), thrombopoietin (TPO) and/or stem cell factor (SCF) to enhance propagation of progenitor cell populations; tissue engineering |
| 06/01/2006 | US20060115897 Compositions and methods modulating variola and vaccinia virus |
| 06/01/2006 | US20060115896 Diagnostic test for west nile virus |
| 06/01/2006 | US20060115895 Fish disease models and uses thereof |
| 06/01/2006 | US20060115894 Method of and apparatus for facilitating processes of mammalian cells |
| 06/01/2006 | US20060115874 Enrichment method for variant proteins with altered binding properties |
| 06/01/2006 | US20060115858 Trace amine 1 receptor of the African green monkey |
| 06/01/2006 | US20060115813 Intracellular signaling molecules |
| 06/01/2006 | US20060115811 Cytochrome p450ra1-2 and related proteins |
| 06/01/2006 | US20060115807 Episomal expression system |
| 06/01/2006 | US20060115805 Gelatine-based materials as swabs |
| 06/01/2006 | US20060115804 Method of studying living cells |
| 06/01/2006 | US20060115545 Methods and means for the manufacture of hyaluronan |
| 06/01/2006 | US20060115496 Toxoplasma gondii proteins, nucleic acid molecules, and uses thereof |
| 06/01/2006 | US20060115482 Modifications of histone proteins as indicators of cell proliferation and differentiation |
| 06/01/2006 | US20060115470 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 06/01/2006 | US20060115464 Use of cardiotrophin to modulate stem cell proliferation |
| 06/01/2006 | US20060115463 Composition of fibroblast or chondrocyte cells transfected or transduced with a gene encoding transforming growth factor beta 1 (TGF- beta 1) or bone morphogenetic protein 2 (BMP-2), and chondrocyte cells that have not been transfected with the gene; generating hyaline cartilage at a target site |
| 06/01/2006 | US20060115460 Compositions and methods comprising WNT proteins to promote repair of damaged tissue |
| 06/01/2006 | US20060115459 Sickle cell anemia treatment |
| 06/01/2006 | US20060115455 Therapeutic RNAi agents for treating psoriasis |
| 06/01/2006 | CA2630475A1 Mer diagnostic and therapeutic agents |
| 06/01/2006 | CA2589279A1 Methods to identify, prepare, and use naive t cell recent thymic emigrants |
| 06/01/2006 | CA2589208A1 Gene trap cassettes for random and targeted conditional gene inactivation |
| 06/01/2006 | CA2589164A1 Production of proteins |
| 06/01/2006 | CA2589151A1 Method for directing nucleic acids to plastids |
| 06/01/2006 | CA2586093A1 Methods for cultivating lawsonia intracellularis |
| 05/31/2006 | EP1662255A2 Homer interacting proteins |
| 05/31/2006 | EP1662003A2 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/31/2006 | EP1662001A2 Expression cassettes for root-preferential expression in plants |
| 05/31/2006 | EP1662000A2 Expression cassettes for guard cell-preferential expression in plants |
| 05/31/2006 | EP1661994A1 Therapeutic agent for NGF |
| 05/31/2006 | EP1661984A1 Method of differentiation from embryo-stem cell of primate to hematogenous cell |
| 05/31/2006 | EP1661979A1 Device and method for uniformly inoculating cell in substrate having three-dimensional surface |
| 05/31/2006 | EP1661577A1 Therapeutic preparation for hematopoietic disease |
| 05/31/2006 | EP1661457A1 Method of constructing offspring originating from frozen sperm stem cell |
| 05/31/2006 | EP1660665A2 Chimaeric vector system |
| 05/31/2006 | EP1660663A2 Methods and compositions for tissue repair |
| 05/31/2006 | EP1660654A1 Expression vector |
| 05/31/2006 | EP1660653A2 Biodegradable polymer-ligand conjugates and their uses in isolation of cellular subpopulations and in cryopreservation, culture and transplantation of cells |
| 05/31/2006 | EP1660646A2 Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
| 05/31/2006 | EP1660645A1 Method for production of neurons from cells of a cell line |
| 05/31/2006 | EP1660644A1 Kidney derived stem cells and methods for their isolation, differentiation and use |
| 05/31/2006 | EP1660643A1 Method of repairing primate mammalian tissue |
| 05/31/2006 | EP1660642A1 Methods of preparing a transplantable product for treatment of skin defects |
| 05/31/2006 | EP1660641A1 Follicular fluid for prolonged growth and survival of cells for cell therapies |
| 05/31/2006 | EP1660633A2 Entrapped stem cells and uses thereof |
| 05/31/2006 | EP1660632A2 Human skin equivalents expressing exogenous polypeptides |
| 05/31/2006 | EP1660629A2 Automated cell culture system and process |
| 05/31/2006 | EP1660627A2 In vitro generation of gabaergic neurons from embryonic stem cells and their use in the treatment of neurological disorders |
| 05/31/2006 | EP1660537A2 Endotheliase-2 ligands |
| 05/31/2006 | EP1660534A2 Humanization of antibodies |
| 05/31/2006 | EP1660513A2 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 05/31/2006 | EP1660502A2 MODULATION OF ß-CATENIN/TCF ACTIVATED TRANSCRIPTION |
| 05/31/2006 | EP1660128A2 Anti-fcrn antibodies for treatment of auto/allo immune conditions |
| 05/31/2006 | EP1660124A2 Antigenic peptides of rabies virus and uses thereof |
| 05/31/2006 | EP1660118A2 Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof |
| 05/31/2006 | EP1660016A2 Sars nucleic acids, proteins, vaccines, and uses thereof |
| 05/31/2006 | EP1659996A2 Citrus sesquiterpene synthase, methods of production and uses thereof |
| 05/31/2006 | EP1659979A1 Three-dimentional tissue structure |
| 05/31/2006 | EP1659859A1 Method for producing avian chimera using spermatogonial cells and avian chimera |
| 05/31/2006 | EP1587928A4 Human saa3 nucleic acid molecule, protein, and methods of use for same |
| 05/31/2006 | EP1534739A4 Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathways |
| 05/31/2006 | EP1385960B1 Cocoa polypeptides and their use in the production of cocoa and chocolate flavour |
| 05/31/2006 | EP1346226B1 Screening method based on siah-numb interaction |
| 05/31/2006 | EP1333845A4 Treatment of t cell disorders |
| 05/31/2006 | EP1313855B1 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 05/31/2006 | EP1285057B1 Isolation of mesenchymal stem cells and use thereof |
| 05/31/2006 | EP1268798B1 Anti-angiogenic properties of vascostatin and fragments or variants thereof |
| 05/31/2006 | EP1250416B1 Artificial three-dimensional mammal heart muscle tissue and process for its manufacture |
| 05/31/2006 | EP1231270B1 Novel protein and dna thereof |
| 05/31/2006 | EP1198580B1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 05/31/2006 | EP1141336B1 Variants of egiii-like cellulase and compositions thereof |
| 05/31/2006 | EP1108014B1 Ehrlichia canis protein |
| 05/31/2006 | EP1068341B1 Particle mediated transformation of soybean with glyphosate selection |
| 05/31/2006 | EP1001028B1 Gene encoding protein having aurone synthesizing activity |
| 05/31/2006 | EP0970228B1 Methods and means for gene silencing in transgenic plants |
| 05/31/2006 | EP0911342B1 Novel protein and process for producing the same |
| 05/31/2006 | EP0888456B1 Prostate specific antigen oligo-epitope peptide |
| 05/31/2006 | EP0796338B1 Encapsidation cell lines for the transcomplementation of defective retroviral vectors |
| 05/31/2006 | EP0791076B1 Diagnostic method and kit for determining kell blood group genotype |
| 05/31/2006 | EP0757717B1 Papillomavirus vaccines |
| 05/31/2006 | EP0689593B1 Inhibition of selected tumor growth with recombinant viral vector |
| 05/31/2006 | EP0631630B1 Control of male fertility using externally inducible promoter sequences |
| 05/31/2006 | CN1780913A Induction of methylation of CpG sequences by dsRNA in mammalian cells |
| 05/31/2006 | CN1780907A Anti-CCR5 antibody |
| 05/31/2006 | CN1780905A Process for the production of biological substances by perfusion culturing of suspended animal cells |
| 05/31/2006 | CN1780856A Human antibodies specific for interleukin 15 (IL-15) |